Pediatric intracranial ependymoma: the roles of surgery, radiation and chemotherapy
- 9 August 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 106 (2), 367-375
- https://doi.org/10.1007/s11060-011-0671-9
Abstract
Management of pediatric intracranial ependymomas poses a major challenge, and optimal treatment remains controversial. We sought to investigate the roles of surgery, radiation, and chemotherapy in a historical cohort. Thirty-nine children, age 21 or younger, with non-metastatic intracranial ependymomas were treated from 1972 to 2008. Median age was 8 years (range 0.2-19.1). Twenty-one patients (54%) underwent GTRs, and 18 (45%) underwent STRs. Twenty-six patients (67%) received upfront adjuvant RT (67%), and 14 (44%) received adjuvant chemotherapy. Twenty-four patients had disease recurrence and 12 died. Only one patient recurred after 5 years. Median PFS was 2.7 years and median OS was 20 years. Fifteen year PFS and OS were 30 and 67%. Adjuvant RT was associated with improved PFS (P = 0.045), and remained significant after adjusting for EOR (P = 0.04). Greater EOR trended towards prolonged survival, but did not reach statistical significance (P = 0.156). Of the patients that underwent GTR, the median PFS was 38 months for those treated with adjuvant RT versus 30 months for those that were not treated with RT. Of the patients that had STR, the median PFS for those treated with RT was 26.3 months versus 6.9 months for those were not treated with RT. In conclusion, for localized intracranial pediatric ependymomas, adjuvant RT is associated with improved PFS, even after adjusting for EOR. Our findings suggest the benefit of RT even in the presence of GTR. Future prospective studies with larger sample number are needed to validate our findings.Keywords
This publication has 40 references indexed in Scilit:
- Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor StudyJNCI Journal of the National Cancer Institute, 2009
- Multifactorial analysis of predictors of outcome in pediatric intracranial ependymomaNeuro-Oncology, 2008
- The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factorsLaboratory Investigation, 2008
- Human Telomere Reverse Transcriptase Expression Predicts Progression and Survival in Pediatric Intracranial EpendymomaJournal of Clinical Oncology, 2006
- Preliminary Results From a Phase II Trial of Conformal Radiation Therapy and Evaluation of Radiation-Related CNS Effects for Pediatric Patients With Localized EpendymomaJournal of Clinical Oncology, 2004
- Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) studyInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Prognostic factors in intracranial ependymomas in childrenJournal of Neurosurgery, 2000
- A Multi-Institutional Retrospective Study of Intracranial Ependymoma in ChildrenJournal of Pediatric Hematology/Oncology, 1999
- Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer GroupJournal of Neurosurgery, 1998
- Treatment of intracranial ependymomas of children: review of a 15-year experienceInternational Journal of Radiation Oncology*Biology*Physics, 1994